Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ABCR, absent, ActionRegistration, aliareflected, alimentary, AllSTAR, alpha, ambition, Amgen, Ancare, andb, andENA, andIncome, anen, ANIA, ankle, Ankleshwar, antacid, antisense, apolipoprotein, ARC, armamentarium, Arrow, ASL, Attal, audio, Auvergne, Aventisub, Bacille, BCG, Biogen, biostatistical, bis, blockade, Bogota, BPCA, Brasilia, Brazilian, breakthrough, BRIC, brokerage, campaign, CE, Chemiphar, Clerk, climate, CNRH, Collaflex, Colombian, commensurate, Commissioner, conceptual, Condorcet, constriction, continental, contrary, cope, coupled, courage, credentialing, Crest, crucial, cut, Daiko, Dairy, degenerative, dermatologist, desperately, detriment, die, dimension, dimerization, dipped, disqualify, divergence, DMA, DMARD, Dosch, downstream, drawable, DTP, Dupilumab, easy, eating, ecosystem, EDITION, EFPIA, EGFR, Egypt, ELIXA, Elmed, eluded, ENA, Enbrel, encompassing, ENCORE, endeavor, endovascular, equate, ERC, everyday, expedite, extremely, fallen, falsified, FDASIA, FDC, feedback, Flagyl, fluid, Flutiform, follitropina, fortune, fourfold, front, Fulai, GBP, gel, Genfar, Gensyme, glucagon, Goa, Gujarat, Hamburg, hamster, Harmonisation, heartburn, Heidelberg, Helmholtz, hematopoietic, Hexacima, Hexaxim, Hexyon, Ib, Idec, IGR, immunomodulatory, indigestion, inflow, inIn, INRA, inseparable, instant, intelligent, interprofessional, intolerant, iPod, Iran, irinotecan, ISICA, itemImpairment, itemIncome, itemNet, itemShare, ITRA, Joslin, judgement, Kaiser, Kako, Klausenburg, Kobayashi, Kynamro, Kyorin, Laurent, lay, leasehold, LEED, LeGoo, leucovorin, Libre, LLM, loop, Lynnwood, Lyxumia, macro, macroeconomic, mammal, Margaret, Maritime, Maroc, marrow, massive, McNeil, MDUFA, meal, Medicrime, Meiji, Methotrexate, MGH, mild, ministerial, Minnesota, missing, mitochondrial, MM, MTX, multaq®, multi, Multivit, myeloma, nanotechnology, narrative, narrower, Nasacort®in, NB, NBs, NCX, nearby, necessitated, neovascularization, Newport, Nigeria, Nihon, Nippon, Nissin, nonfatal, normoglycemia, Novalgine, nutraceutical, obligatory, OFAC, ofaflibercept, ofAllSTAR, ofCertifect, ofMultaq, ofSoloSTAR, ofthymoglobulin, ofZaltrap, ORIGINALE, ourEmerging, Overactive, Paolo, Paulo, perfusion, Permanente, peroxide, Pharm, Pharmacogivilance, photoreceptor, PI, pimasertib, pioneering, pipelinenow, PIs, plerixafor, Pluromed, polymer, portal, Porte, Potier, PRAC, prandial, PREA, predominantly, premarket, presumption, primed, Prize, provideinter, Puy, Pvt, pyrimidine, quantatitive, RA, reauthorization, reauthorizing, reconstituting, refrain, reinspected, reinstated, reiterated, renovation, Replagal, Replivax, Republica, resubmitted, Retino, revascularization, Rheumatologist, rigidly, Rimedio, RTP, Saharan, sampling, sanctionable, Sao, Scotland, Seacod, secretion, sectorial, seize, Selecta, Senator, SETC, settlor, ShanChol, Shiono, shoulder, simulated, slipped, slump, spite, spontaneously, Stamford, Stanford, StarGen, stat, stone, Street, strive, striving, styled, sublicense, surge, Suzano, synovial, Syria, Taisho, Takata, talk, TD, Tehran, TEMSO, ter, theAmbien, theAmortization, theAssociation, theCit, thecompanion, thegreffe, theLancet, theme, thenew, theOncology, theproduction, theTribunal, theUnited, thrust, titrated, TOWER, Trophy, TTF, uncertainty, unconjugated, undermine, undermining, underreported, unfiled, unidentified, unknown, unlocked, unreported, unsubordinated, UshStat, USP, vacine, VaxServe, vehicle, VerorabVax, viable, victim, viscosupplement, Vit, Vivendi, voice, voluntarily, Washington, whichinter, worrying, Worthington, wrongdoing, XI, Yoshindo, yuan, ZD, Zentrum, Zostavax
Removed:
AA, Abengoa, accountant, ACE, acetonide, adding, adjunctive, advancement, Alameda, alarming, alfuzosin, Alnwick, Amphastar, anticipation, appellate, AQ, arguably, artery, asNet, aspirin, assume, avenue, AWP, bacteriological, belt, beneficially, benign, Bermuda, biologically, bisphosphonate, BPH, calcium, Capable, CAPRIE, catheterization, Celivarone, Certifying, cervical, Chimique, cisplatin, Clara, clavicle, clearance, Cobalt, coefficient, combat, community, complication, congestive, converting, coordinating, corneal, costsinclude, cox, creativity, Dausse, debate, DG, Diabel, distressing, Doc, Dodge, dosage, dozen, Eastman, ejaculation, element, enabled, enjoin, entrepreneurial, evolution, expensesin, expensesmainly, exploratory, eye, factory, Farmaceutica, felodipine, Ferrari, fitted, Fonciere, Fondation, foster, fracture, Francopia, frequency, fueled, Gabon, gained, Galderma, GAM, gender, genericization, Genpharm, getgoal, glatiramer, graft, halted, Helvepharm, HexaximTM, highlighted, hydrobromide, hygienic, hyperplasia, hypnotic, imaging, immunomodulating, implantable, inclusive, incomefor, incomeor, Industria, influenzaetype, install, Intensification, interaction, intranasal, IPPC, Iscover, isolated, Ketek, King, Kodak, Kroger, Labaz, Laboratoire, lacking, Lane, Latvia, leg, lentivector, Lichtenstein, lifted, lineRemeasurement, litigated, Luxemburg, lyophilized, magnetic, Marion, Mellon, Merrell, methodologically, MHRA, microcrystalline, MMR, morning, NAQ, Nasacort®AQ, Novopharm, nuclear, ocular, OD, oil, omeprazole, Omnium, onlyafter, opened, ophthalmologic, orthopedic, osteoporotic, Ourdebt, ourstatutsapply, Ourstatutsdo, ourstatutsin, ourstatutsprovide, ourstatutsrelating, Ourstatutsspecify, ourstatutsthat, overcharged, overpaid, Paget, painful, perennial, pharmacological, Piasa, placement, Porcheville, Poulenc, powered, PPSA, profound, proportionally, prostatic, PSSA, Psychiatry, Psychopharmacology, pump, Quimica, Ranbaxy, rataamong, reconfiguration, redefined, refused, remanded, resonance, retailer, retinopathy, revoking, revolution, Romania, Rorer, rubella, rural, Santa, securitization, Shanghai, ShanH, Shop, showing, sixteen, soughtprior, spray, stabilization, storable, Streamlined, stronger, successive, suggestive, symmetrical, symptom, taurocholate, technique, tentative, thestatutscontain, tissue, Tokyo, tract, traditionally, transforming, Treasurer, triamcinolone, tumorselective, Ukraine, unasserted, underRestructuring, underShare, unquantified, unscented, unsuccessful, urinary, Uroxatral, utilizing, VELOUR, vertebral, worth, wrist, Yamanouchi
Filing tables
Filing exhibits
SNY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165418, 333-157685, 333-149203, 333-145074, 333-139555, 333-125490, 333-121584 and Form F-3 No. 333-165472) of Sanofi, of our reports dated March 6, 2013, with respect to the consolidated financial statements of Sanofi and its subsidiaries and the effectiveness of internal control over financial reporting of Sanofi and its subsidiaries, included in this Annual Report (Form 20-F) for the year ended December 31, 2012.
Paris-la Défense, France
March 6, 2013
Ernst & Young et Autres
Represented by Christian Chiarasini